N
Neos Therapeutics
Developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms
About Neos Therapeutics
Neos Therapeutics, Inc. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of innovative central nervous system (CNS) products. The company leverages sophisticated microparticle delivery technology to enable modified release drug delivery of active pharmaceutical ingredients, aiming to provide significant clinical improvements for various disease states. Neos Therapeutics primarily serves patients with ADHD and other CNS-related conditions, operating within the healthcare and pharmaceutical markets. The business model focuses on creating proprietary medications and generating revenue through the sale of these specialized drugs. By continuously advancing its product pipeline and participating in key healthcare conferences, Neos Therapeutics maintains a strong presence in the pharmaceutical industry.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2015
- Outcome tier
- Colt$25–100M revenue
News
Open roles
Neos Therapeutics in the Grand Prairie ecosystem
The Neos Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
- ECEssex Capital Corporation
Presidio Partners- DCDelaware Street Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neos Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neos Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


